» Articles » PMID: 32051425

CNN3 Acts As a Potential Oncogene in Cervical Cancer by Affecting RPLP1 MRNA Expression

Overview
Journal Sci Rep
Specialty Science
Date 2020 Feb 14
PMID 32051425
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The prognosis of advanced stage cervical cancer is poorer due to cancer invasion and metastasis. Exploring new factors and signalling pathways associated with invasiveness and metastasis would help to identify new therapeutic targets for advanced cervical cancer. We searched the cancer microarray database, Oncomine, and found elevated calponin 3 (CNN3) mRNA expression in cervical cancer tissues. QRT-PCR verified the increased CNN3 expression in cervical cancer compared to para-cancer tissues. Proliferation, migration and invasion assays showed that overexpressed CNN3 promoted the viability and motility of cervical cancer cells, the opposite was observed in CNN3-knockdown cells. In addition, xenografted tumours, established from SiHa cells with CNN3 knockdown, displayed decreased growth and metastasis in vivo. Furthermore, RNA-sequencing showed that ribosomal protein lateral stalk subunit P1 (RPLP1) was a potential downstream gene. Gene function experiments revealed that RPLP1 had the same biological effects as CNN3 did. Rescue experiments demonstrated that the phenotypes inhibited by CNN3 silencing were partly or completely reversed by RPLP1 overexpression. In conclusion, we verified that CNN3 acts as an oncogene to promote the viability and motility of cervical cancer cells in vitro and accelerate the growth and metastasis of xenografted tumours in vivo, by affecting RPLP1 expression.

Citing Articles

Ribosomal rodeo: wrangling translational machinery in gynecologic tumors.

Filipek K, Penzo M Cancer Metastasis Rev. 2024; 44(1):13.

PMID: 39621173 PMC: 11611960. DOI: 10.1007/s10555-024-10234-2.


Lactylation Modification as a Promoter of Bladder Cancer: Insights from Multi-Omics Analysis.

He Y, Xiang L, Yuan J, Yan H Curr Issues Mol Biol. 2024; 46(11):12866-12885.

PMID: 39590360 PMC: 11593262. DOI: 10.3390/cimb46110766.


Development of a prognostic model incorporating a cuproptosis-related signature and CNN3 as a predictor in childhood acute myelocytic leukemia.

Cao J, Xie M, Sun K, Zhao Y, Zheng J, Wang Y Front Oncol. 2024; 14:1494777.

PMID: 39555457 PMC: 11564170. DOI: 10.3389/fonc.2024.1494777.


Systematic Analysis of miR-506-3p Target Genes Identified Key Mediators of Its Differentiation-Inducing Function.

Cardus D, Smith M, Vernaza A, Smith J, Del Buono B, Parajuli A Genes (Basel). 2024; 15(10).

PMID: 39457392 PMC: 11507652. DOI: 10.3390/genes15101268.


siRNA-based strategies to combat drug resistance in gastric cancer.

Khaleel A, Alshahrani M, Rizaev J, Malathi H, Devi S, Pramanik A Med Oncol. 2024; 41(11):293.

PMID: 39428440 DOI: 10.1007/s12032-024-02528-w.


References
1.
Kim Y, Lee K, Park K, Kim J, Jung W, Lee R . Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: importance of positive or close parametrial resection margin. Radiat Oncol J. 2015; 33(2):109-16. PMC: 4493422. DOI: 10.3857/roj.2015.33.2.109. View

2.
Van Trappen P, Gyselman V, Lowe D, Ryan A, Oram D, Bosze P . Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet. 2001; 357(9249):15-20. DOI: 10.1016/S0140-6736(00)03566-2. View

3.
Santamaria P, Moreno-Bueno G, Portillo F, Cano A . EMT: Present and future in clinical oncology. Mol Oncol. 2017; 11(7):718-738. PMC: 5496494. DOI: 10.1002/1878-0261.12091. View

4.
Sun Y, Ma L . The emerging molecular machinery and therapeutic targets of metastasis. Trends Pharmacol Sci. 2015; 36(6):349-59. PMC: 4461477. DOI: 10.1016/j.tips.2015.04.001. View

5.
Junghans D, Herzog S . Cnn3 regulates neural tube morphogenesis and neuronal stem cell properties. FEBS J. 2017; 285(2):325-338. DOI: 10.1111/febs.14338. View